Price Alert

Biodexa Pharmaceuticals (BDRX)

NASDAQ: BDRX · Real-Time Price · USD

7.05

0.01 (0.14%)

At close: Aug 18, 2025, 3:59 PM

6.95

-1.42%

Pre-market: Aug 19, 2025, 04:20 AM EDT

0.14% (1D)

Bid	6.58
Market Cap	21
Revenue (ttm)	n/a
Net Income (ttm)	-5.73M
EPS (ttm)	-135.84
PE Ratio (ttm)	-0.05
Forward PE	n/a
Analyst	n/a

Ask	7.24
Volume	26,901
Avg. Volume (20D)	263,052
Open	7.15
Previous Close	7.04
Day's Range	7.03 - 7.24
52-Week Range	5.85 - 163.00
Beta	0.98

About BDRX

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol BDRX

Website n/a

Full Company Profile

Why Price Moved

1 month ago

+12.13%

Biodexa Pharmaceuticals shares are trading higher ... Unlock content with Pro Subscription

2 months ago

+29.4%

Biodexa shares are trading higher after the company enrolled the first patient in its Phase 2a study of Tolimidone.

News

3 weeks ago · accessnewswire.com

How Biodexa Is Racing To Get Its Phase 3 Program in FAP Under Way And Gain First-Mover Advantage in a $7Bn Addressable Market

CARDIFF, UK / ACCESS Newswire / July 28, 2025 / Familial Adenomatous Polyposis (FAP) is an inherited condition that puts people at a much greater risk of developing colon cancer. If left untreated, th...

2 months ago · accessnewswire.com

Biodexa Hits Key Milestone For Its Type 1 Diabetes Candidate Tolimidone, Enrolls First Patient In Phase 2a Study

CARDIFF, UNITED KINGDOM / ACCESS Newswire / June 18, 2025 / When it comes to type 1 diabetes, treating this chronic condition can be difficult. After all, with this type of diabetes, the body's immune...

3 months ago · zacks.com

Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pa...